Trial Profile
Effect of Daclatasvir Plus Sofosbuvir on Angiogenesis in Egyptian Patients With Chronic HCV Infection
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Daclatasvir/sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Pharmacodynamics
- 31 Aug 2018 New trial record